摘要
分析和总结了中医药抗击新冠肺炎中的疗效,以及中医药药物资源、经济学角度和国家政策上的优势。但发现了中医药抗击新冠肺炎的相关文献存在诊疗方案、辨证的不统一、不规范,笔者分析其根源和提出整改的方案。中医药在救治急危重症的所取得巨大成就,推动了中医急危重症学科的发展,团队以此为契机,对中医急危重症学科的发展提出了建议。
This article analyzed and summarized the curative effect of Chinese medicine in fighting against new coronary pneumonia,and the advantages of Chinese medicine resources,economic perspective and national policy.However,it was found that there were different in diagnosis and treatment plan,the syndrome was not uniform and non-standard,and we analyzed its root causes and proposed rectification plans.The great achievements of Chinese medicine in the treatment of acute and critical diseases had promoted the development of the subject of acute and critical diseases of Chinese medicine,and through an interview with Professor Liu Qingquan,for the development of the subject of critical and critical diseases of Chinese medicine.
作者
陈剑明
连博
陈腾飞
徐霄龙
郭玉红
刘清泉
CHEN Jian-ming;LIAN Bo;CHEN Teng-fei;XU Xiao-long;GUO Yu-hong;LIU Qing-quan(Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University,Beijing 100010,China;Beijing Institute of Traditional Chinese Medicine,Beijing 100010,China)
出处
《时珍国医国药》
CAS
CSCD
北大核心
2021年第2期388-393,共6页
Lishizhen Medicine and Materia Medica Research
基金
国家自然科学基金(62041701,81673934,81973608)
北京市自然科学基金(7192083)
中国博士后面上基金(2019M650774)
首都医科大学校级自然科学基金(PYZ19170)
北京市属医院科研培育计划项目(PZ2019009)。
关键词
新型冠状病毒性肺炎
中医药
优势环节
存在问题与解决方案
学科发展
New coronary pneumonia
Traditional Chinese medicine
Advantages
Existing problems and solutions
Discipline development
